US EditionGreensboro’s Once Great Win Is Now A ProKidney Failure - The Rhino Times of Greensboro
Summary by The Rhino Times of Greensboro
1 Articles
1 Articles
All
Left
Center
Right
1
Greensboro’s Once Great Win Is Now A ProKidney Failure - The Rhino Times of Greensboro
Brought to you by the Rhino Times A medical biotech company that not all that long ago was promising to bring a giant production facility and hundreds of new jobs to Greensboro abandoned those plans and, this week, ProKidney stock – which was selling at $13 a share in August of 2023 – closed on Tuesday, April 15, at under a dollar a share, 71 cents a share to be exact. The spectacular fall of the stock price is indicative of what happened to the…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
